Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa – DSP-3077 is an investigational allogeneic iPS ...
Get detailed information about the Premia US Treasury Floating Rate ETF. View the current 3077 stock price chart, historical data, premarket price, dividend returns and more.
All the Latest Game Footage and Images from Hovercars 3077: Underground racing Hovercars 3077: Undeground – flying cars, apocalyptic tracks, difficult weather conditions. Collect and buy cars with ...
Sumitomo Pharma America, Inc. (SMPA) today announced that the first patient in its study evaluating DSP-3077 in the treatment of non-syndromic retinitis pigmentosa (RP) has undergone subretinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results